Acute myocarditis represents an inflammatory disease of the myocardium with highly variable clinical trajectories. Clinicians traditionally expect classic cardiac symptoms, including substernal chest discomfort, progressive dyspnea, or sudden palpitations. However, atypical presentations frequently obscure timely recognition, leading to rapid hemodynamic deterioration before clinicians establish a definitive diagnosis. In particular, extracardiac symptoms such as localized neck pain, dysphagia, and profound systemic inflammatory response can divert attention toward head and neck or infectious etiologies. Recognizing these unconventional manifestations is critical for preventing cardiogenic shock and irreversible multi-organ failure.

Extracardiac Manifestations and Diagnostic Dilemmas in Acute Myocarditis

Acute myocarditis does not always present with predictable cardiac complaints. Instead, systemic inflammation and localized neurovascular irritation can provoke distinct extracardiac features. For instance, severe unilateral neck pain and dysphagia may mimic deep neck space infections, acute thyroiditis, or Lemierre syndrome. Furthermore, these regional symptoms often distract clinicians from underlying cardiac pathology when patients lack overt chest discomfort.

Simultaneously, severe systemic inflammatory responses can trigger profound hematologic and metabolic abnormalities. Patients frequently exhibit marked leukocytosis, thrombocytopenia, and transaminitis, which closely resemble severe bacterial sepsis or toxic shock syndrome. Consequently, medical teams might initially prioritize broad-spectrum antibacterial regimens and intensive septic workups.

However, when acute hemodynamic instability develops in young, previously healthy individuals, clinicians must maintain a high index of suspicion for myocardial involvement. Inflammatory cytokines directly depress myocardial contractility, accelerating the transition from localized inflammation to fulminant cardiac failure. Therefore, early multi-system assessment remains essential to identify cryptic myocardial inflammation before decompensation occurs.

Pathophysiological Links Between Systemic Inflammation and Ventricular Dysfunction

The underlying pathophysiology of acute myocarditis involves complex immune-mediated pathways. An initial viral insult or systemic autoimmune trigger activates both innate and adaptive immune cascades within the myocardium. Subsequently, infiltrating macrophages, T-lymphocytes, and neutrophils release potent pro-inflammatory cytokines, including tumor necrosis factor-alpha, interleukin-1, and interleukin-6.

Moreover, these circulating mediators induce widespread endothelial activation, microvascular dysfunction, and diffuse myocardial edema. The resulting cardiomyocyte injury severely impairs calcium handling and sarcomeric contraction. Consequently, patients can experience an abrupt reduction in left ventricular ejection fraction, precipitating cardiogenic shock. In addition, severe peripheral vasodilation and capillary leakage may accompany cardiac pump failure, creating a mixed cardiogenic and distributive shock state.

Furthermore, systemic cytokine release explains the marked multi-organ involvement observed in fulminant cases. Elevated transaminases and renal markers reflect hypoperfusion combined with systemic inflammatory stress. Thus, the clinician must understand that myocardial dysfunction in this setting is not merely a localized event but rather a severe manifestation of systemic immune dysregulation.

The Indispensable Role of Parametric Cardiac Magnetic Resonance Mapping

Parametric cardiac magnetic resonance mapping has transformed modern diagnostic pathways for acute myocarditis. Conventional imaging modalities, such as standard transthoracic echocardiography, readily quantify left ventricular systolic dysfunction but cannot definitively characterize underlying tissue inflammation. Similarly, conventional late gadolinium enhancement imaging may yield inconclusive results when myocardial injury is diffuse rather than focal.

In contrast, advanced parametric mapping provides quantitative, non-invasive tissue characterization without requiring reference to healthy remote myocardium. Specifically, native T1 mapping and extracellular volume fraction measurements sensitively detect diffuse myocardial edema, myocyte necrosis, and interstitial expansion. In addition, T2 mapping provides direct quantification of active myocardial inflammation, fulfilling the updated Lake Louise criteria.

Consequently, cardiac magnetic resonance mapping resolves diagnostic ambiguity in patients who present with atypical symptoms and non-ischemic cardiogenic shock. When coronary angiography excludes obstructive coronary artery disease, parametric mapping confirms active myocardial inflammation with exceptional accuracy. Therefore, early cardiovascular imaging guides targeted therapy, eliminating the need for invasive endomyocardial biopsy in many clinical scenarios.

Therapeutic Strategies and the Impact of Timely Immunomodulation

The management of acute myocarditis complicated by cardiogenic shock demands rapid, coordinated therapeutic interventions. Initial stabilization focuses on hemodynamic support using tailored inotropic agents and vasopressors to restore adequate organ perfusion. In severe cases, early escalation to mechanical circulatory support, such as temporary intra-aortic balloon counterpulsation or extracorporeal membrane oxygenation, provides vital hemodynamic stability.

Simultaneously, clinicians must systematically exclude active infectious etiologies, including bacterial bacteremia, viral pathogens, and atypical infections. Once infectious causes are ruled out and inflammatory or autoimmune mechanisms are suspected, targeted immunomodulation becomes paramount. High-dose corticosteroid therapy exerts powerful anti-inflammatory effects by suppressing cytokine production and stabilizing cellular membranes.

Consequently, prompt corticosteroid administration can reverse myocardial edema, restore left ventricular contractility, and normalize systemic inflammatory markers within days. In addition, structured guideline-directed medical therapy for heart failure, including beta-blockers and renin-angiotensin-aldosterone system inhibitors, should follow hemodynamic recovery. Therefore, a decisive transition from supportive care to immunosuppression often dictates the reversibility of acute heart failure.

Clinical Practice Insights for Acute Care and Emergency Physicians

Emergency physicians and intensivists encounter tremendous diagnostic challenges when acute myocarditis mimics non-cardiac conditions. Clinicians must recognize that the absence of chest pain or dyspnea does not eliminate the possibility of primary myocardial disease. Therefore, establishing a low threshold for obtaining early electrocardiograms and high-sensitivity cardiac troponins in systemically ill patients is imperative.

Furthermore, point-of-care echocardiography serves as an invaluable bedside tool in the emergency department. Immediate identification of global left ventricular systolic dysfunction or pericardial effusion rapidly shifts the clinical trajectory toward a primary cardiac etiology. Moreover, serial laboratory monitoring of inflammatory markers, platelet counts, and liver enzymes assists in evaluating disease severity and treatment response.

Additionally, interdisciplinary collaboration between emergency medicine, intensive care, cardiology, and radiology teams facilitates prompt diagnostic cardiovascular imaging. Establishing standardized institutional protocols ensures rapid progression from initial stabilization to advanced parametric imaging. Thus, thorough clinical vigilance combined with multimodal diagnostic tools ensures optimal patient outcomes in acute cardiac emergencies.

How can acute myocarditis present with neck pain and dysphagia?

Acute myocarditis can trigger profound systemic inflammation and localized neurovascular irritation, causing referred pain along cervical nerve pathways. Furthermore, severe mediastinal or perivascular inflammation can radiate cranially toward the pharynx and anterior neck. Consequently, patients may experience prominent unilateral neck pain and difficulty swallowing without initial chest discomfort, mimicking acute pharyngeal infections, deep neck cellulitis, or acute thyroiditis before cardiac decompensation occurs.

What diagnostic advantages does parametric cardiac magnetic resonance offer?

Parametric cardiac magnetic resonance mapping quantitatively characterizes myocardial tissue properties without invasive endomyocardial biopsy. Specifically, native T1 mapping and extracellular volume fraction precisely detect diffuse interstitial edema and expanded extracellular space. Furthermore, T2 mapping accurately quantifies active myocardial water content. These quantitative parameters satisfy updated Lake Louise criteria and identify diffuse inflammatory damage even when conventional late gadolinium enhancement imaging appears normal.

When should clinicians consider corticosteroid therapy for acute myocarditis?

Clinicians should consider corticosteroid therapy when acute myocarditis causes progressive hemodynamic compromise or cardiogenic shock after ruling out active infectious etiologies. High-dose corticosteroids effectively suppress severe cytokine release, reduce acute myocardial edema, and restore ventricular systolic function. In addition, systemic autoimmune myocarditis, giant cell myocarditis, and post-viral immune-mediated myocardial injury demonstrate rapid and substantial clinical recovery following early, targeted immunosuppressive administration.

Disclaimer: This content is for informational and educational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

1. Fayyaz A et al. Acute Myocarditis Presenting as Neck Pain With Severe Systemic Inflammation. JACC Case Rep. 2026 Aug 17. doi: undefined. PMID: 42606400.
2. Ferreira VM, Schulz-Menger J, Holmvang G, et al. Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations. J Am Coll Cardiol. 2018;72(24):3158-3176.
3. Tschöpe C, Ammirati E, Bozkurt B, et al. Management of Myocarditis-Related Cardiomyopathy in Adults: Updated European Society of Cardiology Consensus Document. Eur J Heart Fail. 2021;23(5):697-724.